David Wensbo

782 total citations
18 papers, 616 citations indexed

About

David Wensbo is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Wensbo has authored 18 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Wensbo's work include Neuroscience and Neuropharmacology Research (6 papers), Chemical Synthesis and Analysis (3 papers) and Alzheimer's disease research and treatments (3 papers). David Wensbo is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Chemical Synthesis and Analysis (3 papers) and Alzheimer's disease research and treatments (3 papers). David Wensbo collaborates with scholars based in Sweden, Australia and United Kingdom. David Wensbo's co-authors include Salo Gronowitz, Ulf Annby, Louis A. Cohen, Lars Farde, Samuel Svensson, Jan Neelissen, Anders Juréus, Fredrik Jeppsson, Peter Ström and Johan Sandell and has published in prestigious journals such as Journal of Neurochemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

David Wensbo

18 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wensbo Sweden 15 328 189 131 128 46 18 616
Fanxing Zeng United States 13 270 0.8× 109 0.6× 53 0.4× 136 1.1× 22 0.5× 25 521
Eyup Akgün United States 20 337 1.0× 414 2.2× 214 1.6× 417 3.3× 57 1.2× 58 963
Jegadeesan Vaigunda Ragavendran India 13 286 0.9× 164 0.9× 124 0.9× 93 0.7× 27 0.6× 19 562
Céline Bonnefous United States 13 210 0.6× 255 1.3× 48 0.4× 203 1.6× 50 1.1× 18 615
Sham S. Nikam United States 18 310 0.9× 339 1.8× 75 0.6× 207 1.6× 35 0.8× 28 696
Jan W. F. Wasley Switzerland 17 455 1.4× 483 2.6× 97 0.7× 264 2.1× 43 0.9× 39 1.1k
Nagaaki Sato Japan 19 488 1.5× 387 2.0× 69 0.5× 160 1.3× 67 1.5× 48 1.0k
Luis Labeaga Spain 18 356 1.1× 170 0.9× 185 1.4× 107 0.8× 27 0.6× 45 878
Kevin J. Merchant United States 18 509 1.6× 599 3.2× 90 0.7× 454 3.5× 23 0.5× 30 1.3k
François Bischoff Belgium 13 170 0.5× 365 1.9× 98 0.7× 345 2.7× 13 0.3× 22 681

Countries citing papers authored by David Wensbo

Since Specialization
Citations

This map shows the geographic impact of David Wensbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wensbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wensbo more than expected).

Fields of papers citing papers by David Wensbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wensbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wensbo. The network helps show where David Wensbo may publish in the future.

Co-authorship network of co-authors of David Wensbo

This figure shows the co-authorship network connecting the top 25 collaborators of David Wensbo. A scholar is included among the top collaborators of David Wensbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wensbo. David Wensbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Andersson, Jan, Nicholas Seneca, Phong Truong, et al.. (2013). Palladium mediated 11C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [11C]AZD9272. Nuclear Medicine and Biology. 40(4). 547–553. 16 indexed citations
2.
Raboisson, Patrick, Anna Breitholtz‐Emanuelsson, Louise Edwards, et al.. (2012). Discovery and characterization of AZD9272 and AZD6538—Two novel mGluR5 negative allosteric modulators selected for clinical development. Bioorganic & Medicinal Chemistry Letters. 22(22). 6974–6979. 29 indexed citations
3.
Andersson, Jan, Katarina Varnäs, Zsolt Cselényi, et al.. (2010). Radiosynthesis of the candidate β‐amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse. 64(10). 733–741. 23 indexed citations
4.
Swahn, Britt‐Marie, David Wensbo, Johan Sandell, et al.. (2010). Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 20(6). 1976–1980. 24 indexed citations
5.
Wensbo, David, et al.. (2010). Synthesis of novel tetrahydroisoquinoline bronchodilators. Bioorganic & Medicinal Chemistry Letters. 20(17). 4999–5003. 9 indexed citations
6.
Johnson, Allan E., Fredrik Jeppsson, Johan Sandell, et al.. (2008). AZD2184: a radioligand for sensitive detection of β‐amyloid deposits. Journal of Neurochemistry. 108(5). 1177–1186. 105 indexed citations
7.
Hammerland, Lance G., Martin Johansson, Jonas Malmström, et al.. (2006). Structure–activity relationship of thiopyrimidines as mGluR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(9). 2467–2469. 12 indexed citations
8.
Bach, Peter, Karolina Nilsson, Udo Bauer, et al.. (2006). Structure–activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5). Bioorganic & Medicinal Chemistry Letters. 16(18). 4788–4791. 19 indexed citations
9.
Bach, Peter, Karolina Nilsson, Andreas Wållberg, et al.. (2006). A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5). Bioorganic & Medicinal Chemistry Letters. 16(18). 4792–4795. 24 indexed citations
10.
Slassi, Abdelmalik, Methvin Isaac, Louise Edwards, et al.. (2005). Recent Advances in Non-Competitive mGlu5 Receptor Antagonists and their Potential Therapeutic Applications. Current Topics in Medicinal Chemistry. 5(9). 897–911. 42 indexed citations
11.
Wensbo, David, et al.. (2002). On the relative strength of the 1H-tetrazol-5-yl- and the 2-(triphenylmethyl)-2H-tetrazol-5-yl-group in directed ortho-lithiation. Tetrahedron Letters. 43(17). 3137–3139. 38 indexed citations
12.
13.
Wensbo, David, et al.. (1996). Selective removal of the N-BOC protective group using silica gel at low pressure. Tetrahedron Letters. 37(9). 1471–1472. 57 indexed citations
14.
Wensbo, David & Salo Gronowitz. (1996). Indole-3-pyruvic acid oxime ethers and thieno analogues by Heck cyclisation. Application to the synthesis of thia-tryptophans. Tetrahedron. 52(47). 14975–14988. 19 indexed citations
15.
Phillips, Robert S., Louis A. Cohen, Ulf Annby, David Wensbo, & Salo Gronowitz. (1995). Enzymatic synthesis of Thia-L-tryptophans. Bioorganic & Medicinal Chemistry Letters. 5(11). 1133–1134. 18 indexed citations
16.
Wensbo, David, Ulf Annby, & Salo Gronowitz. (1995). Indole-3-Acetic Acids and Hetero Analogues by One Pot Synthesis including Heck Cyclisation. Tetrahedron. 51(37). 10323–10342. 41 indexed citations
17.
Wensbo, David, et al.. (1993). Palladium-catalysed synthesis of heterocondensed pyrroles. Tetrahedron Letters. 34(17). 2823–2826. 79 indexed citations
18.
Wensbo, David, et al.. (1993). A novel approach to bz-substituted tryptophans via Pd-catalysed coupling / annulation.. Tetrahedron Letters. 34(40). 6471–6474. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanxing Zeng Breakdown of academic impact, for papers by Eyup Akgün Breakdown of academic impact, for papers by Jegadeesan Vaigunda Ragavendran Breakdown of academic impact, for papers by Céline Bonnefous Breakdown of academic impact, for papers by Sham S. Nikam Breakdown of academic impact, for papers by Jan W. F. Wasley Breakdown of academic impact, for papers by Nagaaki Sato Breakdown of academic impact, for papers by Luis Labeaga Breakdown of academic impact, for papers by Kevin J. Merchant Breakdown of academic impact, for papers by François Bischoff
Rankless by CCL
2026